142 related articles for article (PubMed ID: 37257242)
21. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
Sun K; Huang C; Li JZ; Luo ZX
World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
[TBL] [Abstract][Full Text] [Related]
22. Ubiquitin C-terminal hydrolase L1 promotes lymph node metastasis in small cell neuroendocrine carcinomas of the cervix.
Zhang Y; Ding J; Zhang X; Hua K
J Int Med Res; 2022 Apr; 50(4):3000605221087620. PubMed ID: 35400238
[TBL] [Abstract][Full Text] [Related]
23. TUSC3 inhibits cell proliferation and invasion in cervical squamous cell carcinoma via suppression of the AKT signalling pathway.
Sun F; Jie Q; Li Q; Wei Y; Li H; Yue X; Ma Y
J Cell Mol Med; 2022 Mar; 26(5):1629-1642. PubMed ID: 35137520
[TBL] [Abstract][Full Text] [Related]
24. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
25. HPV16 E6/E7 stabilize PGK1 protein by reducing its poly-ubiquitination in cervical cancer.
Liu S; Song L; Yao H; Zhang L
Cell Biol Int; 2022 Mar; 46(3):370-380. PubMed ID: 34882921
[TBL] [Abstract][Full Text] [Related]
26. The immune landscape and prognostic analysis of CXCL8 immune-related genes in cervical squamous cell carcinoma.
Zhang X; Yang J; Feng Q; Gu L; Qin G; Cheng C; Hou S; Shi Z
Environ Toxicol; 2024 Apr; ():. PubMed ID: 38597597
[TBL] [Abstract][Full Text] [Related]
27. TPM3: a novel prognostic biomarker of cervical cancer that correlates with immune infiltration and promotes malignant behavior
Zhao YC; Wang TJ; Qu GH; She LZ; Cui J; Zhang RF; Qu HD
Am J Cancer Res; 2023; 13(7):3123-3139. PubMed ID: 37559998
[TBL] [Abstract][Full Text] [Related]
28. High Expression of TMEM33 Predicts Poor Prognosis and Promotes Cell Proliferation in Cervical Cancer.
Chen H; Zhao X; Li Y; Zhang S; Wang Y; Wang L; Ma W
Front Genet; 2022; 13():908807. PubMed ID: 35832191
[No Abstract] [Full Text] [Related]
29. [Clinical significance of σ1 receptor over-expression in cervical cancer and the effect of its synthetic ligands on the growth of cervical cancer cells].
Deng YQ; Zhou XH; Jiang LL; Tang XJ; Zhang YX; Cui JQ
Zhonghua Fu Chan Ke Za Zhi; 2017 Jul; 52(7):473-482. PubMed ID: 28797155
[No Abstract] [Full Text] [Related]
30. The Prognostic and Immune Significance of BZW2 in Pan-Cancer and its Relationship with Proliferation and Apoptosis of Cervical Cancer.
Li C; Li Q; Li L; Sun S; Lei X
Front Biosci (Landmark Ed); 2024 Mar; 29(3):97. PubMed ID: 38538258
[TBL] [Abstract][Full Text] [Related]
31. CXCL10 serves as a potential serum biomarker complementing SCC-Ag for diagnosing cervical squamous cell carcinoma.
Zhang J; Dong D; Wei Q; Ren L
BMC Cancer; 2022 Oct; 22(1):1052. PubMed ID: 36207693
[TBL] [Abstract][Full Text] [Related]
32. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis.
Wu C; Ma C; Yuan J; Zhou P
Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296
[TBL] [Abstract][Full Text] [Related]
33. UCHL1 acts as a potential oncogene and affects sensitivity of common anti-tumor drugs in lung adenocarcinoma.
Yao J; Reyimu A; Sun A; Duoji Z; Zhou W; Liang S; Hu S; Wang X; Dai J; Xu X
World J Surg Oncol; 2022 May; 20(1):153. PubMed ID: 35546675
[TBL] [Abstract][Full Text] [Related]
34. lncRNA HOXA11-AS maintains the stemness of oral squamous cell carcinoma stem cells and reduces the radiosensitivity by targeting miR-518a-3p/PDK1.
Li B; Lv Y; Zhang C; Xiang C
J Oral Pathol Med; 2023 Mar; 52(3):216-225. PubMed ID: 36661031
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma.
Zhang Y; Wang H; Lu J; Lv Q; Yun B; Ge Z; Yan L
Int J Immunopathol Pharmacol; 2023; 37():3946320231178131. PubMed ID: 37232164
[No Abstract] [Full Text] [Related]
36. MiR-1299 is regulated by KCNQ1OT1 and inhibits cervical cancer progression.
Yang Q; Fu J; Wang M; Fang Y; Fu J
Cell Mol Biol (Noisy-le-grand); 2023 Oct; 69(10):166-173. PubMed ID: 37953567
[TBL] [Abstract][Full Text] [Related]
37. Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration.
Jin QQ; Mei J; Hong L; Wang R; Wu SY; Wang SL; Jiang XY; Yang YT; Yao H; Zhang WY; Zhu YT; Ying J; Tian L; Chen G; Zhou SG
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837559
[No Abstract] [Full Text] [Related]
38. Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network.
Dong Y; Wen W; Yuan T; Liu L; Li X
Dis Markers; 2023; 2023():1766080. PubMed ID: 36817087
[TBL] [Abstract][Full Text] [Related]
39. MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
Gong M; Shen F; Li Y; Ming L; Hong L
PLoS One; 2023; 18(8):e0290462. PubMed ID: 37594950
[TBL] [Abstract][Full Text] [Related]
40. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in CESC.
Song J; Ye A; Jiang E; Yin X; Chen Z; Bai G; Zhou Y; Liu J
J Cell Biochem; 2018 Aug; 119(8):6665-6673. PubMed ID: 29741786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]